Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma
| Date | 1st, Mar 2019 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.